Run24 Jul 2018 16:38
The Company’s chosen product candidates, Chemerin and BAM-8, are
both very early in the development stage and even the lead product
candidate, Chemerin, is still in the pre-clinical stage. The Company,
through its scientific collaborators, has only recently completed preclinical
studies with respect to Chemerin and BAM-8 and the Company’s
ability to generate product revenue, which is not expected to occur for
several years, if ever, will depend heavily on the successful development
of the product candidates, many stages of clinical trials and eventual
commercialisation
40 mcap and its pre-clinical.
A few have overlooked the large costs and time involved